The first export operation of MN Pharmaceuticals was to Algeria in 1988-1989. In the subsequent years the number of export countries increased to 14 with 11 million packs with a total value of $8 million.
Mustafa Nevzat İlaç Sanayii A.Ş. has registered its name as MN Pharmaceuticals abroad in 2003.
MN Pharmaceuticals has recently undergone radical changes in its export policy and has gained strength by exporting finished dosage forms, registration files (i.e. ampicillin/sulbactam 2:1 injection was registered in Germany), technology transfer, bulk product export and contract manufacturing for foreign companies.
MN Pharmaceuticals signed strategic partnership agreements with several leading US generic companies for marketing and sales of its products and has submitted the first ANDA file to FDA in 2005. This is also a “first” for Turkish Pharmaceutical Industry. By taking the initial step in exporting finished dosage forms to the US, MN Pharmaceuticals has paved the way for the other Turkish pharmaceutical companies to follow.
Following the FDA approval in November 2006, MN Pharmaceuticals started exporting the finished dosage forms to USA in 2007.
- Please click here to get detailed information about the countries we export to.